Herceptin Proven To Benefit Women With HER2 Positive Early Breast Cancer Latest Results From The HERA Study

Study confirms Herceptin’s promise of extra years of living cancer free The Breast International Group (BIG) in collaboration with Roche announced that women with HER2 positive early breast cancer continue to benefit from Herceptin (trastuzumab) several years after treatment completion and as a result enjoy a longer life disease free. The patients were treated for […]

Pitt School Of Nursing To Sponsor Breast Cancer Conference

The University of Pittsburgh School of Nursing will host a free conference for women living with metastatic breast cancer. Adam Brufsky, M.D., Ph.D., co-director of the Magee Breast Cancer Program of UPMC Cancer Centers and medical director of the Women’s Cancer Center at Magee-Womens Hospital of UPMC, will discuss current and potential treatment options for […]

Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), announced positive safety and efficacy results from its Phase 2 monotherapy clinical study of ProLindac(TM) in late-stage, heavily pretreated ovarian cancer patients. In this monotherapy study 66% of patients who received the highest dose achieved clinically meaningful disease stabilization according to RECIST criteria. No patient in any dose group exhibited […]

Heart Drugs: Brand Names No Better Than Generics, Study

US scientists reviewing 20 years of research and expert opinion on generic versus brand name drugs in the treatment of cardiovascular diseases found no clinical evidence showing brand names were superior to generic versions even though a substantial number of experts writing editorials advised against interchanging them. The study was the work of Dr Aaron […]

Practical Management Of Norovirus Outbreaks – A New One-Day Course From The Royal Institute Of Public Health, Tuesday 13th May 2008, UK

Noroviruses are a group of viruses that are the most common cause of acute gastroenteritis and the HPA estimates that they affect between 600,000 and a million people in the UK each year. Infection can spread rapidly, and as Norovirus outbreaks continue to hit the headlines, the RIPH is pleased to announce it is running […]

The 2008 BIO International Convention Dates Announced

Hosted by the Biotechnology Industry Organization (BIO), the BIO International Convention will take place June 17-20 at the San Diego Convention Center in San Diego, Calif. The convention will highlight all the ways that biotechnology, the life sciences, investments, policy, and the international community work together to heal, fuel, and feed the world. This year, […]

Growth In China’s Biotech Industry

Backed by a government intent on promoting innovation and fuelled by the “brain gain” of talented scientists and entrepreneurs returning from abroad, China’s health biotech industry only needs a more favourable investment climate to emerge as a global force in the production of therapies and medicines – both new and low-cost generics – experts say […]

Scottish Premises Assessment Tool Guide Produced By NPA

The NPA have produced a guide to completing the Pharmacy Premises Assessment Tool for Scottish pharmacy contractors and Health Boards. It follows the circulation of the assessment tool by the Scottish Government in September 2007. The tool must be completed by 31 March 2008 for contractors to qualify for payment. This resource aims to help […]

Way A Drug Concentration Is Expressed Affects Dosing Errors

Epinephrine (adrenaline) is a drug that can be used to treat life-threatening allergies. The drug is stored in salt water and can be expressed as both a dose or mass concentration level (e.g. 1 mg per 1 mL of salt water) and a ratio (1 part drug for every 1000 parts of salt water). This […]

Novartis Pilot Projects Will Shift Marketing Attention To Insurers, HMOs

Novartis officials on Thursday announced pilot projects in three states aimed at developing closer relations with health insurers and HMOs, which increasingly are influencing what medications physicians prescribe, the Wall Street Journal reports. The pilot projects will begin in January 2008 in Minnesota, Oregon and Washington state. According to the Journal, “The move reflects a […]